{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:17:27Z","timestamp":1793485047940,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1053\/j.ajkd.2013.02.366","type":"journal-article","created":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T20:16:34Z","timestamp":1366748194000},"page":"810-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Bone Alkaline Phosphatase in CKD\u2013Mineral Bone Disorder"],"prefix":"10.1053","volume":"62","clinical-trial-number":[{"clinical-trial-number":"nct00261950","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Sunita","family":"Sardiwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.A.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund J.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 suppl 1","key":"10.1053\/j.ajkd.2013.02.366_bib1","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/S0272-6386(00)70239-3","article-title":"Cardiovascular disease and chronic renal disease: a new paradigm","volume":"35","author":"Sarnak","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"13","key":"10.1053\/j.ajkd.2013.02.366_bib2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","article-title":"Chronic kidney disease-mineral-bone disorder: a new paradigm","volume":"14","author":"Moe","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.ajkd.2011.08.009","article-title":"CKD-mineral and bone disorder: core curriculum 2011","volume":"58","author":"Moorthi","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.09580911","article-title":"PTH\u2014a particularly tricky hormone: why measure it at all in kidney patients?","volume":"8","author":"Garrett","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0272-6386(04)00958-8","article-title":"Increased risk of mortality associated with hip fracture in the dialysis population","volume":"44","author":"Mittalhenkle","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2013.02.366_bib9","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib10","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MED.0b013e3283400945","article-title":"Renal bone disease","volume":"17","author":"Sprague","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","article-title":"K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients","volume":"73","author":"Barreto","year":"2008","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5414\/CNP63284","article-title":"New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels","volume":"63","author":"Gal-Moscovici","year":"2005","journal-title":"Clin Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2013.02.366_bib14","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2215\/CJN.01770408","article-title":"Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients","volume":"4","author":"Moore","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-139X.2009.00581.x","article-title":"Parathyroid hormone, a uremic toxin","volume":"22","author":"Rodriguez","year":"2009","journal-title":"Semin Dial"},{"issue":"pt 2","key":"10.1053\/j.ajkd.2013.02.366_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1258\/000456303763046175","article-title":"Stability of parathyroid hormone ex vivo in haemodialysis patients","volume":"40","author":"Teal","year":"2003","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"10.1053\/j.ajkd.2013.02.366_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/clinchem\/46.5.697","article-title":"Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays","volume":"46","author":"Brossard","year":"2000","journal-title":"Clin Chem"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin Chem"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib19","first-page":"3923","article-title":"Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values","volume":"81","author":"Brossard","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1053\/j.ajkd.2013.02.366_bib20","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1373\/clinchem.2006.071589","article-title":"Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions","volume":"52","author":"Cantor","year":"2006","journal-title":"Clin Chem"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib21","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1093\/ndt\/gfr614","article-title":"Variation in parathyroid hormone immunoassay results\u2014a critical governance issue in the management of chronic kidney disease","volume":"26","author":"Sturgeon","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"pt 1","key":"10.1053\/j.ajkd.2013.02.366_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/000456307779596039","article-title":"Parathyroid hormone, kidney disease, evidence and guidelines","volume":"44","author":"Lamb","year":"2007","journal-title":"Ann Clin Biochem"},{"issue":"pt 1","key":"10.1053\/j.ajkd.2013.02.366_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1258\/acb.2011.011094","article-title":"Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease","volume":"49","author":"Almond","year":"2012","journal-title":"Ann Clin Biochem"},{"issue":"7","key":"10.1053\/j.ajkd.2013.02.366_bib24","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2215\/CJN.09471209","article-title":"Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis","volume":"5","author":"Gardham","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2013.02.366_bib25","doi-asserted-by":"crossref","first-page":"e40242","DOI":"10.1371\/journal.pone.0040242","article-title":"Measuring parathyroid hormone (PTH) in patients with oxidative stress\u2014do we need a fourth generation parathyroid hormone assay?","volume":"7","author":"Hocher","year":"2012","journal-title":"PLoS One"},{"issue":"pt 2","key":"10.1053\/j.ajkd.2013.02.366_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1469-1809.1987.tb01056.x","article-title":"The human placental alkaline phosphatase gene and related sequences map to chromosome 2 band q37","volume":"51","author":"Martin","year":"1987","journal-title":"Ann Hum Genet"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0888-7543(88)90095-X","article-title":"Regional assignment of the gene for human liver\/bone\/kidney alkaline phosphatase to chromosome 1p36.1-p34","volume":"2","author":"Smith","year":"1988","journal-title":"Genomics"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0009-8981(90)90031-M","article-title":"The human alkaline phosphatases: what we know and what we don't know","volume":"186","author":"Harris","year":"1990","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1053\/j.ajkd.2013.02.366_bib29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bone.2009.07.009","article-title":"Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms","volume":"45","author":"Halling Linder","year":"2009","journal-title":"Bone"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib30","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00223-001-1137-4","article-title":"Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization","volume":"71","author":"Magnusson","year":"2002","journal-title":"Calcif Tissue Int"},{"issue":"pt 2","key":"10.1053\/j.ajkd.2013.02.366_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3210297","article-title":"Human tissue non-specific alkaline phosphatases: sugar-moiety-induced enzymic and antigenic modulations and genetic aspects","volume":"321","author":"Nosjean","year":"1997","journal-title":"Biochem J"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1359\/jbmr.1997.12.2.210","article-title":"Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency","volume":"12","author":"Magnusson","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/clinchem\/37.6.815","article-title":"Multiple forms of alkaline phosphatase in plasma of hemodialysis patients","volume":"37","author":"Tibi","year":"1991","journal-title":"Clin Chem"},{"issue":"7860","key":"10.1053\/j.ajkd.2013.02.366_bib34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(74)92980-8","article-title":"Letter: Increased intestinal alkaline phosphatase in serum of patients on maintenance haemodialysis","volume":"1","author":"De Broe","year":"1974","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/clinchem\/37.6.783","article-title":"Multiple forms of alkaline phosphatase in plasma of hemodialysis patients","volume":"37","author":"De Broe","year":"1991","journal-title":"Clin Chem"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0003-9861(88)90305-0","article-title":"Alkaline phosphatase is an ectoenzyme that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma (SAOS-2) cells","volume":"264","author":"Fedde","year":"1988","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-8981(97)00161-7","article-title":"Glycosyl-phosphatidylinositol anchored membrane enzymes","volume":"266","author":"Hooper","year":"1997","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib38","first-page":"1325","article-title":"Interaction between osteoblast and osteoclast: impact in bone disease","volume":"19","author":"Phan","year":"2004","journal-title":"Histol Histopathol"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.366_bib39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0002-9440(10)63172-0","article-title":"Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice","volume":"164","author":"Anderson","year":"2004","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s002239900441","article-title":"Skeletal alkaline phosphatase activity is primarily released from human osteoblasts in an insoluble form, and the net release is inhibited by calcium and skeletal growth factors","volume":"62","author":"Anh","year":"1998","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0009-8981(01)00584-8","article-title":"Quantitation of soluble and skeletal alkaline phosphatase, and insoluble alkaline phosphatase anchor-hydrolase activities in human serum","volume":"311","author":"Anh","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1053\/j.ajkd.2013.02.366_bib42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.2010.05387.x","article-title":"Physiological role of alkaline phosphatase explored in hypophosphatasia","volume":"1192","author":"Whyte","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1053\/j.ajkd.2013.02.366_bib43","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.2000.15.10.1879","article-title":"Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice","volume":"15","author":"Wennberg","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib44","doi-asserted-by":"crossref","first-page":"R1365","DOI":"10.1152\/ajpregu.2000.279.4.R1365","article-title":"Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1","volume":"279","author":"Johnson","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"33","key":"10.1053\/j.ajkd.2013.02.366_bib45","doi-asserted-by":"crossref","first-page":"31171","DOI":"10.1074\/jbc.M102788200","article-title":"Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization","volume":"276","author":"Mornet","year":"2001","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1053\/j.ajkd.2013.02.366_bib46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/BF01951980","article-title":"Alkaline phosphatase binds to collagen; a hypothesis on the mechanism of extravesicular mineralization in epiphyseal cartilage","volume":"40","author":"Vittur","year":"1984","journal-title":"Experientia"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","article-title":"Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction","volume":"69","author":"Yamada","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1053\/j.ajkd.2013.02.366_bib48","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/clinchem\/48.10.1731","article-title":"Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy","volume":"48","author":"Bieglmayer","year":"2002","journal-title":"Clin Chem"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib49","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1210\/jcem.83.11.5254","article-title":"Parathyroid hormone after adenectomy for primary hyperparathyroidism","volume":"83","author":"Maier","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/clinchem\/28.1.153","article-title":"Turnover rate of skeletal alkaline phosphatase in humans","volume":"28","author":"Posen","year":"1982","journal-title":"Clin Chem"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.366_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-3476(82)80061-9","article-title":"Infantile hypophosphatasia: enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease","volume":"101","author":"Whyte","year":"1982","journal-title":"J Pediatr"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1523-1755.2001.00794.x","article-title":"Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms","volume":"60","author":"Magnusson","year":"2001","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/abio.1993.1247","article-title":"Methodological aspects on separation and reaction conditions of bone and liver alkaline phosphatase isoform analysis by high-performance liquid chromatography","volume":"211","author":"Magnusson","year":"1993","journal-title":"Anal Biochem"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib54","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1359\/jbmr.1999.14.11.1926","article-title":"Isoforms of bone alkaline phosphatase: characterization and origin in human trabecular and cortical bone","volume":"14","author":"Magnusson","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"1-2","key":"10.1053\/j.ajkd.2013.02.366_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(02)00248-6","article-title":"Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts","volume":"325","author":"Magnusson","year":"2002","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib56","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1203\/00006450-199512000-00021","article-title":"Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents","volume":"38","author":"Magnusson","year":"1995","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0378-4347(92)80177-R","article-title":"Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection","volume":"576","author":"Magnusson","year":"1992","journal-title":"J Chromatogr"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/00365511003642527","article-title":"Circulating and tissue-derived isoforms of bone alkaline phosphatase in Paget's disease of bone","volume":"70","author":"Magnusson","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"issue":"8, pt 1","key":"10.1053\/j.ajkd.2013.02.366_bib59","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/clinchem\/44.8.1621","article-title":"Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain","volume":"44","author":"Magnusson","year":"1998","journal-title":"Clin Chem"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000346161","article-title":"Calcifying human aortic smooth muscle cells express different bone alkaline phosphatase isoforms, including the novel B1x isoform","volume":"50","author":"Haarhaus","year":"2013","journal-title":"J Vasc Res"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib61","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1093\/ndt\/gfp300","article-title":"Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease","volume":"24","author":"Haarhaus","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib62","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00467-006-0231-2","article-title":"The novel bone alkaline phosphatase B1x isoform in children with kidney disease","volume":"21","author":"Swolin-Eide","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.366_bib63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/10408369409084677","article-title":"Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns","volume":"31","author":"Van Hoof","year":"1994","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0009-8981(75)90398-8","article-title":"A simplified heat-inactivation method for investigating alkaline phosphatase isoenzymes in serum","volume":"61","author":"Moss","year":"1975","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1053\/j.ajkd.2013.02.366_bib65","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/clinchem\/30.7.1182","article-title":"Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma","volume":"30","author":"Rosalki","year":"1984","journal-title":"Clin Chem"},{"issue":"12","key":"10.1053\/j.ajkd.2013.02.366_bib66","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/clinchem\/33.12.2171","article-title":"Separation and identification of alkaline phosphatase isoenzymes and isoforms in serum of healthy persons by isoelectric focusing","volume":"33","author":"Griffiths","year":"1987","journal-title":"Clin Chem"},{"issue":"10","key":"10.1053\/j.ajkd.2013.02.366_bib67","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/clinchem\/44.10.2139","article-title":"Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase","volume":"44","author":"Broyles","year":"1998","journal-title":"Clin Chem"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib68","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/clinchem\/41.11.1560","article-title":"Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum","volume":"41","author":"Gomez","year":"1995","journal-title":"Clin Chem"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib69","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0009-8981(90)90050-3","article-title":"The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase","volume":"186","author":"Hill","year":"1990","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1053\/j.ajkd.2013.02.366_bib70","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/clinchem\/40.5.822","article-title":"Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum","volume":"40","author":"Panigrahi","year":"1994","journal-title":"Clin Chem"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib71","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000067254","article-title":"Monoclonal antibodies against tissue-nonspecific alkaline phosphatase","volume":"23","author":"Magnusson","year":"2002","journal-title":"Tumour Biol"},{"issue":"5","key":"10.1053\/j.ajkd.2013.02.366_bib72","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0272-6386(03)00197-5","article-title":"Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients","volume":"41","author":"Bervoets","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2013.02.366_bib73","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","article-title":"Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients","volume":"13","author":"Coen","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib74","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/oxfordjournals.ndt.a027457","article-title":"Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients","volume":"11","author":"Couttenye","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib75","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000189578","article-title":"Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology","volume":"75","author":"Fletcher","year":"1997","journal-title":"Nephron"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2013.02.366_bib76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ndt\/11.supp3.43","article-title":"Bone alkaline phosphatase isoenzyme in renal osteodystrophy","volume":"11","author":"Jarava","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib77","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5414\/CNP70296","article-title":"Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease stages 3-5","volume":"70","author":"Lehmann","year":"2008","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.366_bib78","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.02.366_bib79","unstructured":"Malluche H, Bellorin-Font E, Rojas E, et al. Predictive value of biomarkers for bone turnover in ESKD [abstract]. Presented at American Society of Nephrology Renal Week; November 16-21, 2010; Denver, CO."},{"issue":"15","key":"10.1053\/j.ajkd.2013.02.366_bib80","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.366_bib81","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.03790808","article-title":"Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients","volume":"4","author":"Belozeroff","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.366_bib82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5414\/CNP75181","article-title":"Cinacalcet may reduce arterial stiffness in patients with chronic renal disease and secondary hyperparathyroidism\u2014results of a small-scale, prospective, observational study","volume":"75","author":"Bonet","year":"2011","journal-title":"Clin Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2013.02.366_bib83","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/ndt\/gfs018","article-title":"Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT Study","volume":"27","author":"Ketteler","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2013.02.366_bib84","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.lfs.2005.02.007","article-title":"Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH","volume":"77","author":"Ueda","year":"2005","journal-title":"Life Sci"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib85","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10157-012-0665-8","article-title":"Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism","volume":"17","author":"Tsuruta","year":"2013","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib86","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1542-4758.2009.00430.x","article-title":"Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients","volume":"14","author":"Park","year":"2010","journal-title":"Hemodial Int"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib87","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.2012.77","article-title":"Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients","volume":"82","author":"Sardiwal","year":"2012","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.366_bib88","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11906-012-0265-8","article-title":"Vascular calcification: pathophysiology and risk factors","volume":"14","author":"Chen","year":"2012","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.366_bib89","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/CS20090631","article-title":"Vascular calcification in chronic kidney disease","volume":"119","author":"Covic","year":"2010","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"10.1053\/j.ajkd.2013.02.366_bib90","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/ki.2008.417","article-title":"Calcimimetics, parathyroid hormone, and vascular calcification in chronic kidney disease","volume":"74","author":"Coen","year":"2008","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib91","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1093\/ndt\/gfr591","article-title":"The connections between vascular calcification and bone health","volume":"26","author":"Cannata-Andia","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib92","first-page":"318","article-title":"Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients","volume":"54","author":"Block","year":"2000","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.366_bib93","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0272-6386(96)90363-7","article-title":"Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients","volume":"27","author":"Braun","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2013.02.366_bib94","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/ndt\/gfq582","article-title":"Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients","volume":"26","author":"Noordzij","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2013.02.366_bib95","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib96","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","article-title":"Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins","volume":"61","author":"Moe","year":"2002","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib97","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1172\/JCI116391","article-title":"Bone morphogenetic protein expression in human atherosclerotic lesions","volume":"91","author":"Bostrom","year":"1993","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib98","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1172\/JCI117501","article-title":"Diffuse calcification in human coronary arteries","volume":"94","author":"Fitzpatrick","year":"1994","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib99","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI117246","article-title":"High expression of genes for calcification-regulating proteins in human atherosclerotic plaques","volume":"93","author":"Shanahan","year":"1994","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib100","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1172\/JCI116755","article-title":"Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques","volume":"92","author":"Giachelli","year":"1993","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1053\/j.ajkd.2013.02.366_bib101","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/sj.ki.5000297","article-title":"Chemical and hormonal determinants of vascular calcification in vitro","volume":"69","author":"Lomashvili","year":"2006","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib102","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","article-title":"Pathophysiology of vascular calcification in chronic kidney disease","volume":"95","author":"Moe","year":"2004","journal-title":"Circ Res"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib103","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pharma.2009.04.001","article-title":"Pathophysiological mechanisms and consequences of cardiovascular calcifications: role of uremic toxicity","volume":"67","author":"Chillon","year":"2009","journal-title":"Ann Pharm Fr"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib104","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/01.ASN.0000128955.83129.9C","article-title":"Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin","volume":"15","author":"Lomashvili","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2013.02.366_bib105","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.2008.26","article-title":"Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification","volume":"73","author":"Lomashvili","year":"2008","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2013.02.366_bib106","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ki.2010.461","article-title":"Treatment with pyrophosphate inhibits uremic vascular calcification","volume":"79","author":"O'Neill","year":"2011","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2013.02.366_bib107","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/ndt\/gfr039","article-title":"Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia","volume":"26","author":"Riser","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2013.02.366_bib108","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.2001.281.1.C1","article-title":"Inorganic pyrophosphate generation and disposition in pathophysiology","volume":"281","author":"Terkeltaub","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib109","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.070714","article-title":"Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification","volume":"22","author":"Narisawa","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"1-2","key":"10.1053\/j.ajkd.2013.02.366_bib110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cccn.2004.11.026","article-title":"Alkaline phosphatase is involved in the control of adipogenesis in the murine preadipocyte cell line, 3T3-L1","volume":"354","author":"Ali","year":"2005","journal-title":"Clin Chim Acta"},{"issue":"pt 3","key":"10.1053\/j.ajkd.2013.02.366_bib111","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1258\/000456306776865179","article-title":"The effect of alkaline phosphatase inhibitors on intracellular lipid accumulation in preadipocytes isolated from human mammary tissue","volume":"43","author":"Ali","year":"2006","journal-title":"Ann Clin Biochem"},{"issue":"22","key":"10.1053\/j.ajkd.2013.02.366_bib112","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/WNL.0b013e3181ff966a","article-title":"Increased serum alkaline phosphatase as a predictor of long-term mortality after stroke","volume":"75","author":"Ryu","year":"2010","journal-title":"Neurology"},{"issue":"18","key":"10.1053\/j.ajkd.2013.02.366_bib113","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.109.851873","article-title":"Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality","volume":"120","author":"Tonelli","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib114","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.amjmed.2010.11.030","article-title":"Associations of serum alkaline phosphatase with metabolic syndrome and mortality","volume":"124","author":"Krishnamurthy","year":"2011","journal-title":"Am J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib115","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2215\/CJN.08621209","article-title":"Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization","volume":"5","author":"Abramowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2013.02.366_bib116","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2008.03.039","article-title":"Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999-2004","volume":"135","author":"Cheung","year":"2009","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1053\/j.ajkd.2013.02.366_bib117","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2008.248","article-title":"High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death","volume":"74","author":"Blayney","year":"2008","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib118","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib119","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2013.02.366_bib120","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/ndt\/gfq144","article-title":"Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD","volume":"25","author":"Kovesdy","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2013.02.366_bib121","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2215\/CJN.01910212","article-title":"Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes","volume":"7","author":"Molnar","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2013.02.366_bib122","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","article-title":"Bone alkaline phosphatase and mortality in dialysis patients","volume":"6","author":"Drechsler","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5-6","key":"10.1053\/j.ajkd.2013.02.366_bib123","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.lfs.2011.11.006","article-title":"Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients","volume":"90","author":"Kobayashi","year":"2012","journal-title":"Life Sci"},{"key":"10.1053\/j.ajkd.2013.02.366_bib124","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-1-4684-7758-0_44","article-title":"Pathogenesis of renal osteodystrophy: roles of phosphate and skeletal resistance to PTH","volume":"103","author":"Ritz","year":"1978","journal-title":"Adv Exp Med Biol"},{"issue":"4 suppl 4","key":"10.1053\/j.ajkd.2013.02.366_bib125","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2008.11.029","article-title":"Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP)","volume":"53","author":"Bhuriya","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2013.02.366_bib126","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/clinchem.2009.136754","article-title":"Influence of blood sampling site on intact parathyroid hormone concentrations in hemodialysis patients","volume":"56","author":"Vulpio","year":"2010","journal-title":"Clin Chem"},{"issue":"26","key":"10.1053\/j.ajkd.2013.02.366_bib127","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib128","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2215\/CJN.01370211","article-title":"Sclerostin: just one more player in renal bone disease?","volume":"6","author":"Drueke","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2013.02.366_bib129","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness","volume":"90","author":"Thambiah","year":"2012","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"10.1053\/j.ajkd.2013.02.366_bib130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.mnh.0000172717.49476.80","article-title":"Role of fibroblast growth factor 23 in health and in chronic kidney disease","volume":"14","author":"Fukagawa","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613005866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613005866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:10:05Z","timestamp":1759457405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638613005866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":130,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0272638613005866"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.02.366","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone Alkaline Phosphatase in CKD\u2013Mineral Bone Disorder","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.02.366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}